YKL-40/CHI3L1 Drives Inflammation on the Road of Tumor Progression

Journal of Leukocyte Biology - United States
doi 10.1189/jlb.3vmr0415-142r
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Inflammation in Tumor Progression

Folia Pharmacologica Japonica
Pharmacology
2011English

Inhibition of Mammalian Glycoprotein YKL-40

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Serum YKL-40 and Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Bruselloz Hastalarında Serum YKL-40 Düzeylerinin Belirlenmesi

Turkish Journal of Clinics and Laboratory
2019English

Genetic and Epigenetic Regulation of YKL-40 in Childhood

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

YKL-40 - An Emerging Biomarker in Cardiovascular Disease and Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2009English

Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression

Cancer Research
Cancer ResearchOncology
2019English

Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy